$5.09

-0.19 (-3.60%)

5/16/2008 4:00 PM

Halozyme Therapeutics, Inc. (HALO)

CAPS Rating:

A biopharmaceutical company dedicated to the development and commercialization of recombinant human enzymes for the drug delivery, palliative care, oncology and infertility markets.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other players to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating HALO

Add Stock to Watchlist

What the Community Thinks

Total Players

167 Outperforms

31 Underperforms

All-Stars

38 Outperforms

17 Underperforms

Wall Street

3 Outperforms

2 Underperforms

Players bullish on HALO are also bullish on:

Players bearish on HALO are also bearish on:

Ticker Tags

Biotechnology (291), Micro Cap (4824)
Suggest a tag

Halozyme Therapeutics, Inc. At A Glance

Current Price:	$5.09
Last Trade Time:	5/16/2008 4:00 PM
Open:	$5.35
Previous Close:	$5.28
Daily Range:	$4.96 - $5.35
52-Week Range:	$4.19 - $10.85
Volume:	317,273
Market Cap:	$419.85M
P/E Ratio:	0.00
Compare Our Special Broker Offers!

Stock Trends

HALO VS S&P 500 (SPY)

News & Discussion Boards

Sorry no news articles available for HALO.

Top Bull Pitch

Recs

4 Halozyme Therapeutics, Inc. (HALO)

Avatar icemeta2 (< 20) Submitted: 3/16/07 8:18 AM

Just signed a $600 million deal with Roche, a $100+ million deal with Baxter, and has a drug comimg to market in 6 months, there are only 35 employees, production is jobbed out saving capital exp and mfg problems. The only stock I have that could be 20x in 3 years.

Replies: 0 | Reply | Permalink

Top Bear Pitch

Recs

5 Halozyme Therapeutics, Inc. (HALO)

Avatar davidmelnikov (< 20) Submitted: 12/19/06 10:20 AM

1. roche deal not that great.
2. stock overvalued
3. company exists of 19 employees
4. no disaster recovery in place, company can be wiped out.
5. to many pumpers/blogs bringing the stock price up for no reason.

Replies: 2 | Reply | Permalink

CAPS Players

Show Me:

Sort by:

picks per page. CHANGE

Results 1 - 5 of 35 : 1 2 3 4 5 Next »

Recs 0 (HALO) jmofield (66.49) Submitted: 5/13/08 6:31 PM : Start Price: $5.30 HALO Score: 5.65 I have decided for the next serveral weeks to change my investment strategy to be short stocks trading between $1.50 and below $10 with a market cap of more than $100 million. My goal is to acheive at least a 60% sucess rate of beating the S&P Index. I am looking for 30% of my picks beating the S&P Index by more than 5% with an average per pick of at least 1.50. I am only looking to hold these positions for approximately 10-15 days. All the picks that I select are from screening criteria that I have developed using software from Vectorvest. I find it to be a good screening tool. For game playing purposes, since I always try to have 200 picks going at once, it's a shot gun approach with only short term trading in mind. Report this Post Replies: 0 \| Reply \| Permalink Oops! There appears to be a problem with your comment. Check to see if there's something you left out. Recs 0 (HALO) gdesignr (< 20) Submitted: 3/20/08 9:22 AM : Start Price: $6.15 HALO Score: -26.93 This stock seems to truly have a halo around it and should perform nicely as a mover and a shaker. Jump on now to cash in. Report this Post Replies: 0 \| Reply \| Permalink Oops! There appears to be a problem with your comment. Check to see if there's something you left out. Recs 0 (HALO) icemeta (< 20) Submitted: 12/03/07 9:17 PM : Start Price: $7.46 HALO Score: -29.04 Explosive drug collaboration, $100 million cash, no debt, director just bought 20% of stock, incredible market opportunity, my largest position Report this Post Replies: 0 \| Reply \| Permalink Oops! There appears to be a problem with your comment. Check to see if there's something you left out. Recs 0 (HALO) zzlangerhans (< 20) Submitted: 10/22/07 6:14 AM : Start Price: $8.80 HALO Score: -37.99 Price has not increased much since announcement of Roche deal in 12/06, despite several positive developments. Given the strong partnerships and solid technology, stock will likely gap up again with good data from Baxter or Roche. Company is also an acquisition candidate for Baxter which is currently cash-heavy. Report this Post Replies: 0 \| Reply \| Permalink Oops! There appears to be a problem with your comment. Check to see if there's something you left out. Recs 0 (HALO) CayG (< 20) Submitted: 9/14/07 7:39 PM : Start Price: $8.70 HALO Score: -37.68 HALO is one of the few stocks I own that I believe will tripple in less than 2 years. Lots of brain power behind this one. Great management, great tech and new relationships with big players will get them there... a lot faster than most would think. Report this Post Replies: 0 \| Reply \| Permalink Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
Results 1 - 5 of 35 : 1 2 3 4 5 Next »

Wall Street

Results 1 - 5 of 5

picks per page. CHANGE

Top Pick	Player Name	Player Rating	Start Date	Call	Time Frame	Start Price	Stock Gain	S&P Gain	Score	Pitch
	TrackMorganJos	< 20	09/11/07		NS	$9.17	-44.49%	-2.45%	+42.04
	TrackOppenheimer	< 20	07/24/07		NS	$9.28	-45.15%	-6.83%	-38.32
	TrackJimCramer	80.65	12/13/06		3W	$7.07	-28.01%	+0.17%	+28.17
	TrackBreanMurray	88.12	12/07/06		NS	$4.58	+11.14%	+0.41%	+10.72
	TrackJefferies	89.06	12/01/06		NS	$2.89	+76.12%	+1.52%	+74.61

Results 1 - 5 of 5

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.